Pathogenesis of nonalcoholic steatohepatitis (NASH)

被引：0
|
作者：
Pirlich, M [1 ]
Lochs, H [1 ]
Schmidt, HHJ [1 ]
机构：
[1] Univ Klinikum Charite, Med Klin Schwerpunkt Gastroenterol Hepatol & Endo, D-10098 Berlin, Germany
来源：
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2001年 / 39卷 / 05期
关键词：
D O I：
10.1055/s-2001-13706
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：441 / 442
页数：2
相关论文
共 50 条
  • [41] Serum markers of fibrogenesis and fibrosis in nonalcoholic steatohepatitis (NASH).
    Costanzo, M
    Miele, L
    Di Rocco, P
    Forgione, A
    Alfei, B
    Pompili, M
    Rapaccini, GL
    Grieco, A
    Gasbarrini, G
    [J]. HEPATOLOGY, 2002, 36 (04) : 412A - 412A
  • [42] Potential biomarkers in the fibrosis progression of nonalcoholic steatohepatitis (NASH)
    Wang, Z.
    Zhao, Z.
    Xia, Y.
    Cai, Z.
    Wang, C.
    Shen, Y.
    Liu, R.
    Qin, H.
    Jia, J.
    Yuan, G.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2022, 45 (07) : 1379 - 1392
  • [43] The Central Zone "Portalization" Phenomenon in Nonalcoholic Steatohepatitis (NASH)
    Oliver-Krasinski, J. M.
    Peruyero, L. C.
    Moreira, R. K.
    [J]. MODERN PATHOLOGY, 2012, 25 : 420A - 421A
  • [44] The role of liver MTP activity in nonalcoholic steatohepatitis (NASH)
    Fujita, Koji
    Imajyo, Kento
    Nozaki, Yuichi
    Yoneda, Masato
    Kirikoshi, Hiroyuki
    Saito, Satoru
    Wada, Koichiro
    Nakajima, Atsushi
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 28P - 28P
  • [45] Innate immunity involved in the pathogenesfs of nonalcoholic steatohepatitis (NASH)
    不详
    [J]. LIVER TRANSPLANTATION, 2006, 12 (10) : 1553 - 1554
  • [46] Insulin Resistance, Reason or Consequence Nonalcoholic Steatohepatitis (NASH)
    Akbari, Hamed
    Vakili, Sina
    Aria, Hamid
    Taghadosi, Roholah
    Alavi, Seyed Ali
    [J]. RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2015, 6 (03): : 1861 - 1865
  • [47] Predicting nonalcoholic steatohepatitis (NASH) using mechanistic biomarkers
    Tan, Eunice
    Jumat, Nur Halisa
    Soon, Gwyneth Shook Ting
    Lee, Jonathan Wei Jie
    Dan, Yock Young
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 425 - 425
  • [48] Cells to Prevent the Development and Progression of Nonalcoholic Steatohepatitis (NASH)
    Sun, Guangyong
    Zhang, Chunpan
    Jin, Hua
    Shi, Wen
    Wang, Tianqi
    Zhang, Dong
    [J]. HEPATOLOGY, 2018, 68 : 64A - 64A
  • [49] Elafibranor: a potential drug for the treatment of nonalcoholic steatohepatitis (NASH)
    Van Meeteren, Menso J. Westerouen
    Drenth, Joost P. H.
    Tjwa, Eric T. T. L.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (02) : 117 - 123
  • [50] The Central Zone "Portalization" Phenomenon in Nonalcoholic Steatohepatitis (NASH)
    Oliver-Krasinski, J. M.
    Peruyero, L. C.
    Moreira, R. K.
    [J]. LABORATORY INVESTIGATION, 2012, 92 : 420A - 421A
12345